Apixaban/rivaroxabanBleeding: 3 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2019年 / 1744卷 / 1期

关键词：

D O I：

10.1007/s40278-019-58950-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：51 / 51

相关论文

共 50 条

[1] Apixaban/warfarin/rivaroxabanBleeding: 2 case reports
[J]. Reactions Weekly, 2017, 1657 (1) : 48 - 48
[2] Apixaban/rivaroxabanBleeding events : 8 case reports
[J]. Reactions Weekly, 2022, 1909 (1) : 90 - 90
[3] Apixaban/dabigatran etexilate/rivaroxabanBleeding and haematomas: 12 case reports
[J]. Reactions Weekly, 2018, 1733 (1) : 60 - 60
[4] Andexanet alfa/apixaban/rivaroxabanBleeding and lack of efficacy: 9 case reports
[J]. Reactions Weekly, 2019, 1767 (1) : 41 - 41
[5] Apixaban/rivaroxabanBleeding following off label use: 11 case reports
[J]. Reactions Weekly, 2018, 1697 (1) : 65 - 65
[6] Apixaban/rivaroxabanBleeding following off label use: 10 case reports
[J]. Reactions Weekly, 2018, 1695 (1) : 56 - 56
[7] RivaroxabanBleeding: 6 case reports
[J]. Reactions Weekly, 2020, 1799 (1) : 332 - 332
[8] RivaroxabanBleeding: 2 case reports
[J]. Reactions Weekly, 2018, 1720 (1) : 226 - 226
[9] RivaroxabanBleeding event: case reports
[J]. Reactions Weekly, 2016, 1597 (1) : 185 - 185
[10] RivaroxabanBleeding: 2 case reports
[J]. Reactions Weekly, 2018, 1683 (1) : 601 - 601

← 1 2 3 4 5 →